Skin and oral lesions associated to imatinib mesylate therapy

Please use this identifier to cite or link to this item: http://repositorio.unicamp.br/jspui/handle/REPOSIP/348668

Type:	Artigo
Title:	Skin and oral lesions associated to imatinib mesylate therapy
Author:	Basso, Fernanda Gonçalves Boer, Camila Cominato Corrêa, Maria Elvira Pizzigatti Torrezan, Marcia Cintra, Maria Letícia Magalhães, Marina H. C. Gallottini de Santos, Paulo da Silva Souza, Cármino Antônio de
Abstract:	Imatinib mesylate is a tyrosine kinase inhibitor used to treat chronic myeloid leukemia (CML) throughout all the phases of the disease. In most cases, this drug is well tolerated; however, some cases experience side effects. Skin rashes and oral lesions are uncommon and appear to be dose-dependent. The authors report two cases of CML Ph+ in chronic phase patients who presented skin and oral lesions probably induced by imatinib therapy
Subject:	Imatinibe Efeitos colaterais
Country:	Alemanha
Editor:	Springer
Rights:	Fechado
Identifier DOI:	10.1007/s00520-008-0536-8
Address:	https://link.springer.com/article/10.1007%2Fs00520-008-0536-8
Date Issue:	2009
Appears in Collections:	FCM - Artigos e Outros Documentos HEMO - Artigos e Outros Documentos

Files in This Item:

File	Description	Size	Format
000264183100018.pdf		301.66 kB	Adobe PDF	View/Open